Exploring Syringa vulgaris: From Traditional Remedy to Modern Therapy
đ 10 slides
đ 48 views
đ
1/22/2026
Introduction to Syringa vulgaris
Syringa vulgaris leaves hold untapped potential in modern pharmacology.
2
Research Objectives
- Define the phytochemical profile of Syringa vulgaris leaves.
- Analyze anti-inflammatory and antioxidant mechanisms.
- Connect historical use to contemporary scientific evidence.
- Identify key bioactive compounds for future applications.
3
Methodology
- Integrated review of phytochemical and pharmacological studies (2013-2023).
- Data sourced from PubMed, ScienceDirect, and Scopus.
- Keywords included secoiridoids, oleuropein, and NF-ÎșB.
- HPLC-MS analyses linked compounds to biological activity.
4
Unique Chemical Profile
- Rich in secoiridoids like oleuropein and demethyloleuropein.
- Dominant phenylpropanoid: syringin, a key marker compound.
- Supporting flavonoids such as rutin enhance bioactivity.
- Distinct from flowers or bark, leaves offer specific benefits.
5
Antioxidant Capacity
- High phenolic content neutralizes free radicals effectively.
- DPPH and FRAP assays confirm significant antioxidant activity.
- Combats oxidative stress linked to chronic diseases and aging.
- Validates traditional use in managing inflammatory conditions.
6
Anti-inflammatory Effects
- Dose-dependent suppression of ROS in immune cells.
- Reduces Interleukin-8 (IL-8), a key inflammatory signal.
- Modulates cellular response to inflammation.
- Confirms mechanistic basis for ethnomedical applications.
7
Molecular Mechanisms
- Oleuropein and syringin inhibit NF-ÎșB pathway activation.
- Modulates MAPK pathways (p38, JNK) to reduce COX-2 production.
- Dual-pathway inhibition explains anti-inflammatory effects.
- Provides a rational basis for standardized phytopharmaceuticals.
8
Potential Cytotoxic Activity
- Preliminary evidence of dose-dependent cytotoxicity in HeLa cells.
- Suggests induction of apoptosis via redox imbalance.
- Highlights potential for future cancer research.
- Requires dedicated studies to explore therapeutic implications.
9
Key Findings
- Validated traditional uses with modern scientific evidence.
- Identified oleuropein and syringin as bioactive principals.
- Elucidated dual inhibition of NF-ÎșB and MAPK pathways.
- Noted cytotoxic potential for further exploration.
10
Next Steps
- Conduct toxicological studies in animal models.
- Perform pharmacokinetic analysis of key compounds.
- Validate efficacy in chronic inflammation models like arthritis.
- Develop standardized phytopharmaceutical or nutraceutical preparations.
1 / 10